Early Decline in Serum Phospho-Cse1l Levels in Vemurafenib/Sunitinib-Treated Melanoma and Sorafenib/Lapatinib-Treated Colorectal Tumor Xenografts
Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-015-0553-6
Full Text
Open PDFAbstract
Available in full text
Date
June 13, 2015
Authors
Publisher
Springer Science and Business Media LLC